Summary
An investigation by the BBC found errors in drug warnings for medications used to treat Parkinson's and other conditions. These errors may have misled many families about potential side effects like impulsive behaviors. The UK's drug safety regulator is now reviewing and updating these warnings.
Key Facts
- The investigation focused on drugs used for Parkinson's and Restless Legs Syndrome that can lead to impulsive behaviors such as gambling or sex addiction.
- More than 350 people contacted the BBC about the effects of these drugs over a year.
- A significant study found that one in six Parkinson's patients taking these drugs experience impulse control disorders.
- Drug leaflets incorrectly described these side effects as "uncommon," affecting fewer than one in 100 patients.
- The UK's Medicines and Healthcare products Regulatory Agency is changing the status of these side effects to "common."
- The drug company Boehringer Ingelheim, the developer of Pramipexole, stated it is committed to patient safety.
- The MHRA is reviewing warnings for eight medications associated with impulse control issues.
- Layla Moran, an MP, has called for answers from the MHRA and believes the agency should apologize to affected families.
